Cargando…
An optimized integrin α6‐targeted peptide for positron emission tomography/magnetic resonance imaging of pancreatic cancer and its precancerous lesion
Autores principales: | Mei, Yan, Li, Ying‐He, Yang, Xiao‐Chun, Zhou, Chao, Li, Zhi‐Jian, Zheng, Xiao‐Bin, Ye, Jia‐Cong, Li, Cheng, Zhang, Xuan‐Hong, Yuan, Jian‐Min, Huang, Hui‐Qiang, Fan, Wei, Zhang, Wei‐Guang, Zeng, Mu‐Sheng, Feng, Guo‐Kai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7449243/ https://www.ncbi.nlm.nih.gov/pubmed/32898323 http://dx.doi.org/10.1002/ctm2.157 |
Ejemplares similares
-
Integrin α6-Targeted Positron Emission Tomography
Imaging of Colorectal Cancer
por: Xiao, Yi-Tai, et al.
Publicado: (2019) -
Positron emission tomography alone, positron emission tomography-computed tomography and computed tomography in diagnosing recurrent cervical carcinoma: a systematic review and meta-analysis
por: Xiao, Yi, et al.
Publicado: (2014) -
Quantitative accuracy of positron emission tomography/magnetic resonance and positron emission tomography/computed tomography for cervical cancer
por: Oldan, Jorge Daniel, et al.
Publicado: (2018) -
Radiochemistry for positron emission tomography
por: Rong, Jian, et al.
Publicado: (2023) -
Glucose Metabolism Measured by Positron Emission Tomography is Reduced in Patients with White Matter Presumably Ischemic Lesions
por: Li, Jian, et al.
Publicado: (2014)